Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysis
- PMID: 37781646
- PMCID: PMC10509955
- DOI: 10.1016/j.jacig.2023.100157
Effect of the COVID-19 pandemic on asthma exacerbations in New Zealand: An interrupted time series analysis
Abstract
Background: New Zealand (NZ) implemented some of the strictest restrictions during the novel coronavirus pandemic (coronavirus disease 2019 [COVID-19]), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). How this impacted asthma exacerbation rates in NZ is unknown.
Objective: We sought to explore the effects of the COVID-19 restrictions on asthma exacerbations in NZ during 2020.
Methods: We used a population-based, interrupted time series to examine the impact of the first COVID-19 lockdown in NZ on asthma exacerbation rate. The primary outcome measure was change in the monthly exacerbation rate, defined as hospitalization and/or course of corticosteroids, before and after the first lockdown. In a secondary analysis, we quantified the number of patients with asthma, the actual asthma exacerbation rate from March to December 2019 versus March to December 2020, and the number of asthma hospitalizations.
Results: There was a significant drop in the exacerbation rate immediately after lockdown (-3.02; P < .0001) followed by a significant and sustained increasing trend; the rate postlockdown increased relative to that prelockdown (0.27; P < .0001). Similar patterns were observed in all sociodemographic groups. In our secondary analysis, we identified 507,622 people with asthma; this reduced to 458,023 in 2020 postlockdown. The overall asthma exacerbation rate was 33.3% less in 2020 than in 2019 (reduction from 48.6/1000 patients to 32.4/1000 patients). The rate of asthma hospitalizations decreased from 9.5 per 1000 patients in 2019 to 6.2 per 1000 patients in 2020; this decrease was observed across all demographic groups.
Conclusions: The first COVID-19 lockdown in 2020 in NZ significantly reduced asthma exacerbation rates across all sociodemographic groups. Whether these reductions are sustained requires further investigation.
Keywords: Asthma; COVID-19; exacerbations; hospitalizations; interrupted time series; pandemic; public health.
© 2023 The Authors.
Figures
Similar articles
-
Impact of COVID-19 national lockdown on asthma exacerbations: interrupted time-series analysis of English primary care data.Thorax. 2021 Sep;76(9):860-866. doi: 10.1136/thoraxjnl-2020-216512. Epub 2021 Mar 29. Thorax. 2021. PMID: 33782080 Free PMC article.
-
The effect of the COVID-19 lockdown on children with asthma-related symptoms: A tertiary care center experience.Pediatr Pulmonol. 2021 Sep;56(9):2825-2832. doi: 10.1002/ppul.25505. Epub 2021 Jun 14. Pediatr Pulmonol. 2021. PMID: 34126003 Free PMC article.
-
The Impact of Social Distancing in 2020 on Admission Rates for Exacerbations in Asthma: A Nationwide Cohort Study.J Allergy Clin Immunol Pract. 2022 Aug;10(8):2086-2092.e2. doi: 10.1016/j.jaip.2022.04.020. Epub 2022 Apr 29. J Allergy Clin Immunol Pract. 2022. PMID: 35500879 Free PMC article.
-
Impact of the COVID-19 on asthma control among children: A systematic review.J Public Health Res. 2023 Sep 8;12(3):22799036231197186. doi: 10.1177/22799036231197186. eCollection 2023 Jul. J Public Health Res. 2023. PMID: 37693736 Free PMC article. Review.
-
Asthma, severe acute respiratory syndrome coronavirus-2 and coronavirus disease 2019.Curr Opin Allergy Clin Immunol. 2021 Apr 1;21(2):182-187. doi: 10.1097/ACI.0000000000000720. Curr Opin Allergy Clin Immunol. 2021. PMID: 33399389 Review.
Cited by
-
Real-world use of inhaled corticosteroid/formoterol as needed in adults with mild asthma: the PRIME study.ERJ Open Res. 2024 Sep 30;10(5):00174-2024. doi: 10.1183/23120541.00174-2024. eCollection 2024 Sep. ERJ Open Res. 2024. PMID: 39351383 Free PMC article.
-
Seasonal variation of pediatric asthma exacerbations and its association with asthma phenotypes.Pediatr Res. 2025 May 7. doi: 10.1038/s41390-025-04073-2. Online ahead of print. Pediatr Res. 2025. PMID: 40335642
-
COVID-19 severity and risk of SARS-CoV-2-associated asthma exacerbation by time since booster vaccination: a longitudinal analysis of data from the COVIDENCE UK study.BMJ Open Respir Res. 2025 May 15;12(1):e003158. doi: 10.1136/bmjresp-2025-003158. BMJ Open Respir Res. 2025. PMID: 40379262 Free PMC article.
-
The Indirect Impact of COVID-19 Pandemic on Mortality, Complications, and Healthcare Utilization Among Patients With Chronic Respiratory Diseases in Hong Kong: An Interrupted Time Series Analysis.J Evid Based Med. 2025 Jun;18(2):e70039. doi: 10.1111/jebm.70039. J Evid Based Med. 2025. PMID: 40442886 Free PMC article.
-
Associations of aeroallergen testing with reduced oral corticosteroid bursts among adults with asthma.J Allergy Clin Immunol Glob. 2024 Oct 17;4(1):100348. doi: 10.1016/j.jacig.2024.100348. eCollection 2025 Feb. J Allergy Clin Immunol Glob. 2024. PMID: 39583037 Free PMC article.
References
-
- Jackson T., Mcclatchey K., Chan A., Morgan N., Pinnock H. Exploring the psychological impact of the COVID-19 pandemic on adults with asthma: a qualitative study. Eur Respir J. 2021;58:PA3563.
LinkOut - more resources
Full Text Sources
Miscellaneous